Online inquiry

IVTScrip™ mRNA-Human ADGRD1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8934MR)

This product GTTS-WK8934MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADGRD1 protein. This product can be used in FGFR1 High NME5-epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001330497.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 283383
UniProt ID Q6QNK2
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADGRD1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8934MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK8340MR IVTScrip™ mRNA-Human ADGRF5, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADGRF5
GTTS-WK12190MR IVTScrip™ mRNA-Human ADAM15, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ADAM15
GTTS-WK12885MR IVTScrip™ mRNA-Human AFG3L2, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA AFG3L2
GTTS-WK5327MR IVTScrip™ mRNA-Human CD24, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA CD24
GTTS-WK20698MR IVTScrip™ mRNA-Human APBB1, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA APBB1
GTTS-WK9382MR IVTScrip™ mRNA-Human ABRACL, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ABRACL
GTTS-WK23274MR IVTScrip™ mRNA-Human ARPP21, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARPP21
GTTS-WK12759MR IVTScrip™ mRNA-Human ACTG1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ACTG1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →